Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis

Miguel Oliveira Santosa Institute of Physiology, Instituto de Medicina Molecular João Lobo Antunes, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;b Department of Neurosciences and Mental Health, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, PortugalView further author information

Mamede de Carvalhoa Institute of Physiology, Instituto de Medicina Molecular João Lobo Antunes, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;b Department of Neurosciences and Mental Health, Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon, PortugalCorrespondence[email protected]
View further author information

Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date